Alnylam Pharmaceuticals, Inc. (ALNY)
USD 241.95
(-7.71%)
USD 241.95
(-7.71%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.86 Billion USD | 312.01% |
| 2022 | 453.85 Million USD | 155.52% |
| 2021 | 177.61 Million USD | 621.76% |
| 2020 | 24.6 Million USD | 110.11% |
| 2019 | -243.35 Million USD | 37.62% |
| 2018 | -390.14 Million USD | 36.6% |
| 2017 | -615.36 Million USD | -1310.83% |
| 2016 | -43.61 Million USD | 96.59% |
| 2015 | -1.28 Billion USD | -45.24% |
| 2014 | -881.92 Million USD | -1558.73% |
| 2013 | -53.16 Million USD | -3.43% |
| 2012 | -51.4 Million USD | 26.8% |
| 2011 | -70.22 Million USD | 5.86% |
| 2010 | -74.59 Million USD | 45.73% |
| 2009 | -137.46 Million USD | 28.32% |
| 2008 | -191.79 Million USD | -94.91% |
| 2007 | -98.39 Million USD | 17.19% |
| 2006 | -118.81 Million USD | -1320.94% |
| 2005 | -8.36 Million USD | 36.03% |
| 2004 | -13.07 Million USD | 38.73% |
| 2003 | -21.33 Million USD | -37.84% |
| 2002 | -15.47 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 2 Billion USD | 7.08% |
| 2024 Q2 | 1.73 Billion USD | -13.12% |
| 2024 Q3 | 201.9 Million USD | -88.39% |
| 2023 Q4 | 1.86 Billion USD | 577.48% |
| 2023 FY | 1.86 Billion USD | 312.01% |
| 2023 Q3 | 276.01 Million USD | -57.96% |
| 2023 Q1 | 648.09 Million USD | 42.8% |
| 2023 Q2 | 656.53 Million USD | 1.3% |
| 2022 Q3 | 250.65 Million USD | -39.66% |
| 2022 Q2 | 415.41 Million USD | -9.95% |
| 2022 Q1 | 461.3 Million USD | 159.72% |
| 2022 FY | 453.85 Million USD | 155.52% |
| 2022 Q4 | 453.85 Million USD | 81.07% |
| 2021 Q4 | 177.61 Million USD | 153.25% |
| 2021 FY | 177.61 Million USD | 621.76% |
| 2021 Q3 | -333.55 Million USD | -2279.35% |
| 2021 Q1 | 138.97 Million USD | 464.75% |
| 2021 Q2 | 15.3 Million USD | -88.99% |
| 2020 Q1 | -162.95 Million USD | 33.04% |
| 2020 Q2 | -265.76 Million USD | -63.09% |
| 2020 Q3 | -167.25 Million USD | 37.07% |
| 2020 Q4 | 24.6 Million USD | 114.71% |
| 2020 FY | 24.6 Million USD | 110.11% |
| 2019 Q1 | -395.68 Million USD | -1.42% |
| 2019 FY | -243.35 Million USD | 37.62% |
| 2019 Q4 | -243.35 Million USD | 60.67% |
| 2019 Q3 | -618.68 Million USD | 22.64% |
| 2019 Q2 | -799.73 Million USD | -102.11% |
| 2018 Q1 | -366.14 Million USD | 40.5% |
| 2018 Q2 | -331.45 Million USD | 9.47% |
| 2018 FY | -390.14 Million USD | 36.6% |
| 2018 Q4 | -390.14 Million USD | -36.13% |
| 2018 Q3 | -286.6 Million USD | 13.53% |
| 2017 Q3 | -52.04 Million USD | 79.88% |
| 2017 Q1 | -21.07 Million USD | 51.67% |
| 2017 FY | -615.36 Million USD | -1310.83% |
| 2017 Q4 | -615.36 Million USD | -1082.36% |
| 2017 Q2 | -258.67 Million USD | -1127.15% |
| 2016 Q4 | -43.61 Million USD | -136.01% |
| 2016 Q3 | -18.48 Million USD | 84.74% |
| 2016 Q1 | -231.27 Million USD | 81.94% |
| 2016 Q2 | -121.07 Million USD | 47.65% |
| 2016 FY | -43.61 Million USD | 96.59% |
| 2015 Q2 | -1.39 Billion USD | 3.72% |
| 2015 Q1 | -1.45 Billion USD | -64.5% |
| 2015 Q3 | -149.21 Million USD | 89.32% |
| 2015 Q4 | -1.28 Billion USD | -758.44% |
| 2015 FY | -1.28 Billion USD | -45.24% |
| 2014 Q2 | -80.72 Million USD | 76.97% |
| 2014 Q4 | -881.92 Million USD | -966.15% |
| 2014 Q1 | -350.58 Million USD | -559.39% |
| 2014 FY | -881.92 Million USD | -1558.73% |
| 2014 Q3 | -82.72 Million USD | -2.47% |
| 2013 Q3 | -11.84 Million USD | 52.59% |
| 2013 Q4 | -53.16 Million USD | -349.06% |
| 2013 FY | -53.16 Million USD | -3.43% |
| 2013 Q1 | -97.8 Million USD | -90.26% |
| 2013 Q2 | -24.97 Million USD | 74.46% |
| 2012 Q1 | -61.73 Million USD | 12.09% |
| 2012 FY | -51.4 Million USD | 26.8% |
| 2012 Q4 | -51.4 Million USD | 32.22% |
| 2012 Q3 | -75.83 Million USD | -57.1% |
| 2012 Q2 | -48.27 Million USD | 21.81% |
| 2011 Q4 | -70.22 Million USD | 5.53% |
| 2011 FY | -70.22 Million USD | 5.86% |
| 2011 Q3 | -74.33 Million USD | -10.77% |
| 2011 Q2 | -67.11 Million USD | 25.92% |
| 2011 Q1 | -90.59 Million USD | -21.44% |
| 2010 Q3 | -46.88 Million USD | 29.16% |
| 2010 Q1 | -114.94 Million USD | 16.38% |
| 2010 Q2 | -66.18 Million USD | 42.42% |
| 2010 FY | -74.59 Million USD | 45.73% |
| 2010 Q4 | -74.59 Million USD | -59.12% |
| 2009 Q1 | -227.26 Million USD | -18.5% |
| 2009 Q3 | -98.08 Million USD | 33.67% |
| 2009 Q4 | -137.46 Million USD | -40.15% |
| 2009 Q2 | -147.87 Million USD | 34.94% |
| 2009 FY | -137.46 Million USD | 28.32% |
| 2008 Q3 | -192.79 Million USD | 20.54% |
| 2008 Q4 | -191.79 Million USD | 0.52% |
| 2008 Q2 | -242.63 Million USD | -27.41% |
| 2008 Q1 | -190.43 Million USD | -93.54% |
| 2008 FY | -191.79 Million USD | -94.91% |
| 2007 FY | -98.39 Million USD | 17.19% |
| 2007 Q3 | -192.89 Million USD | -154.01% |
| 2007 Q2 | -75.94 Million USD | -30.25% |
| 2007 Q1 | -58.3 Million USD | 50.93% |
| 2007 Q4 | -98.39 Million USD | 48.99% |
| 2006 Q2 | -26.59 Million USD | 46.26% |
| 2006 Q3 | -26.03 Million USD | 2.09% |
| 2006 FY | -118.81 Million USD | -1320.94% |
| 2006 Q1 | -49.47 Million USD | -491.7% |
| 2006 Q4 | -118.81 Million USD | -356.42% |
| 2005 Q4 | -8.36 Million USD | -2366.12% |
| 2005 Q2 | -1.2 Million USD | 72.98% |
| 2005 Q1 | -4.44 Million USD | 65.96% |
| 2005 FY | -8.36 Million USD | 36.03% |
| 2005 Q3 | 369 Thousand USD | 130.7% |
| 2004 Q1 | -19.73 Million USD | 7.5% |
| 2004 FY | -13.07 Million USD | 38.73% |
| 2004 Q4 | -13.07 Million USD | -72.58% |
| 2004 Q3 | -7.57 Million USD | 71.08% |
| 2004 Q2 | -26.18 Million USD | -32.7% |
| 2003 Q4 | -21.33 Million USD | 0.0% |
| 2003 FY | -21.33 Million USD | -37.84% |
| 2002 FY | -15.47 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 3442.757% |
| Alkermes plc | -166.73 Million USD | 1221.476% |
| Agenus Inc. | 274.13 Million USD | -582.121% |
| Aptorum Group Limited | 1.35 Million USD | -137694.739% |
| Ardelyx, Inc. | 34.51 Million USD | -5318.226% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -43590.14% |
| Bicycle Therapeutics plc | -481.46 Million USD | 488.383% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -5070.86% |
| ChromaDex Corporation | -24.04 Million USD | 7875.857% |
| Chimerix, Inc. | -25.51 Million USD | 7428.205% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -26735.787% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 7997.698% |
| CRISPR Therapeutics AG | -150.84 Million USD | 1339.642% |
| Precision BioSciences, Inc. | -85.41 Million USD | 2289.367% |
| Dyadic International, Inc. | -6.37 Million USD | 29418.109% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 11836.258% |
| Fortress Biotech, Inc. | 7.66 Million USD | -24295.799% |
| Lantern Pharma Inc. | -21.7 Million USD | 8715.924% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 1791.685% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 21988.089% |
| Incyte Corporation | -3.17 Billion USD | 158.894% |
| IO Biotech, Inc. | -140.69 Million USD | 1429.034% |
| Jaguar Health, Inc. | 29.39 Million USD | -6262.281% |
| Novavax, Inc. | -298.29 Million USD | 726.878% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -34937.249% |
| Opthea Limited | 28.15 Million USD | -6541.007% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 11237.876% |
| ContextLogic Inc. | -232 Million USD | 906.008% |
| MiMedx Group, Inc. | -33.9 Million USD | 5615.879% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -18241.717% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 80804.196% |
| NextCure, Inc. | -6.47 Million USD | 28970.434% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 3802.774% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 29413.968% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -15273.649% |
| Vaxcyte, Inc. | -368.22 Million USD | 607.822% |
| PDS Biotechnology Corporation | -32.7 Million USD | 5816.909% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -10722.653% |
| Pharming Group N.V. | 109.8 Million USD | -1602.978% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 10849.241% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 1167.133% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 10196.936% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 10196.936% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 26437.155% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 32010.205% |
| Acelyrin, Inc. | -216.9 Million USD | 962.108% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 33430.642% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 108565.081% |
| Summit Therapeutics Inc. | 34.67 Million USD | -5292.911% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 27586.962% |
| Senti Biosciences, Inc. | 1.74 Million USD | -107367.701% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 1112.929% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 2514.35% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 30946.882% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -1874167.558% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -297660.828% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 1697.609% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 1211.517% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -1586.604% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 24717.404% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 1548.284% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -27021.784% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 871.544% |
| Immix Biopharma, Inc. | -17.5 Million USD | 10779.385% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 690.439% |
| MEI Pharma, Inc. | -3.7 Million USD | 50570.661% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -14846.351% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -1056.124% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -6628.09% |
| Fortress Biotech, Inc. | 7.66 Million USD | -24295.799% |
| Precigen, Inc. | -481 Thousand USD | 388860.499% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -13179.866% |
| AlloVir, Inc. | -62.69 Million USD | 3082.738% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 3462.351% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -2932.365% |
| ImmuCell Corporation | 10.99 Million USD | -16914.034% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 1313.095% |
| Onconetix, Inc. | 5.33 Million USD | -34973.808% |
| PureTech Health plc | -167.19 Million USD | 1218.404% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 6238.995% |
| Elevation Oncology, Inc. | -19.11 Million USD | 9881.034% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 38192.035% |
| Seer, Inc. | -4.24 Million USD | 44202.311% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 7879.415% |
| Innoviva, Inc. | 255.56 Million USD | -631.694% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 3447.304% |
| ESSA Pharma Inc. | -33.62 Million USD | 5661.719% |
| GlycoMimetics, Inc. | -40.98 Million USD | 4662.557% |
| GT Biopharma, Inc. | -1.02 Million USD | 183247.698% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 2858.712% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -2952.611% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 1494.654% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 13595.511% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 6576.649% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 2482296.618% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 6159.031% |
| Aptose Biosciences Inc. | -8.19 Million USD | 22918.434% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 59861.177% |
| Soligenix, Inc. | -4.95 Million USD | 37864.341% |
| Century Therapeutics, Inc. | 847 Thousand USD | -220671.901% |
| Kura Oncology, Inc. | -20.11 Million USD | 9394.85% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 4669.071% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 22366.468% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -102548.248% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 58590.397% |
| Autolus Therapeutics plc | -186.59 Million USD | 1102.116% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 3892.67% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 778.02% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -5356.805% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -1037.653% |
| GRI Bio, Inc. | -1.79 Million USD | 104332.887% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 20916.302% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 5722.69% |
| IGM Biosciences, Inc. | -72.6 Million USD | 2675.459% |
| INmune Bio, Inc. | -25.41 Million USD | 7458.774% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -1138.772% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 3791.225% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 11607.755% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 64917.538% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -4818.948% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 4640.338% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -5764.632% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -394.757% |
| Verastem, Inc. | -37.27 Million USD | 5116.197% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 20709.92% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 3705.603% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 12455.058% |
| Histogen Inc. | -7.48 Million USD | 25075.798% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 8754.388% |
| Surrozen, Inc. | -32.66 Million USD | 5824.767% |
| Organovo Holdings, Inc. | -1.5 Million USD | 124183.477% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 44585.389% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -9762.434% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -71380.81% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -44893.696% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 22411.234% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 4404.447% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 12928.126% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 690.279% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 259072.662% |
| Apollomics, Inc. | -27.39 Million USD | 6925.837% |
| Amarin Corporation plc | -191.04 Million USD | 1078.82% |
| Mesoblast Limited | 55.96 Million USD | -3241.383% |
| Turnstone Biologics Corp. | -14.58 Million USD | 12921.846% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 7493.397% |
| Synaptogenix, Inc. | -28.66 Million USD | 6624.216% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 199879.701% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -3737.187% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 217007.767% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 25835.169% |
| Exelixis, Inc. | -73.05 Million USD | 2659.806% |
| Better Therapeutics, Inc. | -860 Thousand USD | 217534.651% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 7887.19% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 874.715% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -253944.882% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 25239.877% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -149017.863% |
| Gritstone bio, Inc. | 39.49 Million USD | -4635.219% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 2323.443% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 71142.498% |
| Avid Bioservices, Inc. | 169.72 Million USD | -1001.726% |
| Insmed Incorporated | 721.62 Million USD | -159.131% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 20555.456% |
| MediWound Ltd. | -5.32 Million USD | 35236.002% |
| OmniAb, Inc. | 9.2 Million USD | -20218.787% |
| Alector, Inc. | -35.63 Million USD | 5347.181% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -2075.08% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 38045.17% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -14024.466% |
| Zai Lab Limited | -775 Million USD | 341.282% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -449.085% |
| Aura Biosciences, Inc. | -21.52 Million USD | 8787.285% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 2367.141% |
| Immunic, Inc. | -45.34 Million USD | 4224.257% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 1067.802% |
| Veracyte, Inc. | -203.82 Million USD | 1017.428% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -192.959% |
| FibroGen, Inc. | 56.76 Million USD | -3194.058% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -20898.742% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 66243.748% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 90419.985% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 59.264% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 56069.41% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 1226.713% |
| TG Therapeutics, Inc. | 17.86 Million USD | -10368.805% |
| Galecto, Inc. | -21.21 Million USD | 8913.81% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 7961.837% |
| Fortrea Holdings Inc. | 1.56 Billion USD | -19.15% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 7741.133% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 16350.439% |
| XBiotech Inc. | -200.02 Million USD | 1034.861% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 2323.443% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -41197.217% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 5402.833% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 2521.635% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -32757.811% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 1197.285% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 2124.312% |
| Vaxxinity, Inc. | 10.13 Million USD | -18355.764% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | -153.976% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 17466.419% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 2935.129% |
| NexImmune, Inc. | -3.13 Million USD | 59772.975% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 54259.14% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 12474.312% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 7000.14% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 20932.52% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 1501153.984% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 4708.937% |
| Ainos, Inc. | 4.07 Million USD | -45755.101% |
| Pluri Inc. | 22.82 Million USD | -8091.064% |
| Prothena Corporation plc | -608.34 Million USD | 407.38% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 1674.605% |
| Celularity Inc. | 65.19 Million USD | -2768.443% |
| Rallybio Corporation | -24.1 Million USD | 7858.435% |
| Cue Biopharma, Inc. | -33.81 Million USD | 5629.253% |
| MeiraGTx Holdings plc | -40.3 Million USD | 4739.814% |
| Omeros Corporation | 331.17 Million USD | -464.636% |
| Humacyte, Inc. | -22.48 Million USD | 8416.01% |
| Immunocore Holdings plc | -358.59 Million USD | 621.464% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 7709.107% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 6151.383% |
| Blueprint Medicines Corporation | 702.83 Million USD | -166.056% |
| CalciMedica, Inc. | -5.53 Million USD | 33914.43% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 1093.485% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 18407.597% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 4770.525% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 5723.366% |
| Pulmatrix, Inc. | -10.41 Million USD | 18050.83% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 31385.561% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 5002.569% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 1778.55% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 3219.474% |
| Cytokinetics, Incorporated | 642.37 Million USD | -191.099% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 32212.966% |
| Nutriband Inc. | -251.65 Thousand USD | 743150.263% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 5580.635% |
| Vor Biopharma Inc. | 4.3 Million USD | -43386.93% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 130.98% |
| Evogene Ltd. | -19.63 Million USD | 9623.979% |
| ProKidney Corp. | -56.23 Million USD | 3425.162% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 3941.917% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 20343.587% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | -37.102% |
| CorMedix Inc. | -43.05 Million USD | 4443.39% |
| BioLineRx Ltd. | 7.33 Million USD | -25389.885% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 6908.44% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -3952.133% |
| Atai Life Sciences N.V. | -28.55 Million USD | 6647.86% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -83733.835% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 8295.731% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -10443.772% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 2590.793% |
| MediciNova, Inc. | -50.78 Million USD | 3782.175% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 2472.867% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 8312782.818% |
| GeoVax Labs, Inc. | -6.45 Million USD | 29079.655% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 1035.807% |
| Biomea Fusion, Inc. | -166.57 Million USD | 1222.614% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 1144.804% |
| Mereo BioPharma Group plc | -51.46 Million USD | 3733.135% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 2071.593% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 736.555% |
| Absci Corporation | -72.59 Million USD | 2675.743% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -40853.526% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 897.629% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 2084.84% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 2054.04% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 4885.755% |
| Allakos Inc. | -24.97 Million USD | 7587.239% |
| Imunon, Inc. | -4.21 Million USD | 44475.977% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 12784.425% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 1481.047% |
| BioAtla, Inc. | -109.01 Million USD | 1815.366% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -253944.882% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 199241.427% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -15527.093% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 8919.214% |
| XOMA Corporation | -29 Million USD | 6548.062% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 11391.896% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 20840.217% |
| aTyr Pharma, Inc. | -7.44 Million USD | 25203.208% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 1600.319% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 998.3% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 2386.575% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 2115.823% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 217741.157% |
| Akari Therapeutics, Plc | -3.84 Million USD | 48732.978% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -115122.72% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | -35.417% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 157484.304% |
| UroGen Pharma Ltd. | 4.39 Million USD | -42485.698% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -1547.798% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -2598407.546% |
| Orgenesis Inc. | 21.78 Million USD | -8483.997% |
| Entera Bio Ltd. | -10.62 Million USD | 17692.793% |
| GH Research PLC | -78.07 Million USD | 2494.992% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 8489.887% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 7114.284% |
| Xencor, Inc. | 29.64 Million USD | -6207.981% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 95029.77% |
| Replimune Group, Inc. | 1.41 Million USD | -132331.87% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 763626.712% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 1579.182% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 157484.304% |
| Portage Biotech Inc. | -4.98 Million USD | 37641.417% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 8312782.818% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 2928.012% |
| OncoCyte Corporation | -6.56 Million USD | 28592.123% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -208269.836% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 41146.632% |
| Purple Biotech Ltd. | -14.13 Million USD | 13326.326% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 7971.435% |
| scPharmaceuticals Inc. | -6.54 Million USD | 28670.481% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 11302.489% |
| HilleVax, Inc. | -165.48 Million USD | 1229.974% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 73777.62% |
| Tharimmune, Inc. | -10.93 Million USD | 17199.934% |
| Genprex, Inc. | -6.73 Million USD | 27853.65% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 607.023% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 2213.88% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 133571.663% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 56475.292% |
| OKYO Pharma Limited | -826.84 Thousand USD | 226252.57% |
| Savara Inc. | 153 Thousand USD | -1222081.699% |
| Curis, Inc. | -23.88 Million USD | 7928.266% |
| Daré Bioscience, Inc. | -5.15 Million USD | 36353.786% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 241067.665% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 30221.424% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -157700.675% |
| BeiGene, Ltd. | -2.25 Billion USD | 182.994% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -15055.311% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 407.452% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 1107.586% |
| Erasca, Inc. | -37.21 Million USD | 5124.554% |
| bluebird bio, Inc. | 108.57 Million USD | -1622.318% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 145293.584% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -393.716% |
| DBV Technologies S.A. | -126.98 Million USD | 1572.554% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 145293.584% |
| Moderna, Inc. | -2.9 Billion USD | 164.325% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 18163.543% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 17305.907% |
| Molecular Templates, Inc. | 707 Thousand USD | -264389.109% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 6060.722% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -439.496% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 2378.689% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 2138.524% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 5894.305% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 5539.661% |
| MacroGenics, Inc. | -66.98 Million USD | 2891.577% |
| RenovoRx, Inc. | -1.17 Million USD | 159515.004% |
| Adicet Bio, Inc. | -138.78 Million USD | 1447.344% |
| Prime Medicine, Inc. | -27.94 Million USD | 6792.452% |
| Aditxt, Inc. | 18.12 Million USD | -10219.242% |
| Adagene Inc. | -87.62 Million USD | 2233.965% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 44991.857% |
| Quantum-Si incorporated | -118.55 Million USD | 1677.248% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -5093.551% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 25118.611% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 3954.827% |
| SciSparc Ltd. | -2.06 Million USD | 90653.898% |
| Vericel Corporation | 1.27 Million USD | -146332.106% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 15693.601% |
| Minerva Neurosciences, Inc. | 41 Million USD | -4460.352% |
| Generation Bio Co. | 31.44 Million USD | -5846.127% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 1166.318% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 6147.078% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -1503.817% |
| Invivyd, Inc. | -198.47 Million USD | 1042.148% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 2171.494% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 78089.204% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 2741.528% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 27498.359% |
| 2seventy bio, Inc. | 181.71 Million USD | -929.05% |
| ADMA Biologics, Inc. | 90.06 Million USD | -1976.186% |
| Clene Inc. | 3.34 Million USD | -55886.168% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 20687.902% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 8792.938% |
| GeoVax Labs, Inc. | -6.45 Million USD | 29079.655% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 643.391% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 7292.157% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -952.502% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 45802.246% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -37283.806% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 35998.215% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 1535.058% |
| Evaxion Biotech A/S | 5.28 Million USD | -35269.646% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 1761.163% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 1524.465% |
| Trevena, Inc. | 2.25 Million USD | -82713.906% |
| Surrozen, Inc. | -32.66 Million USD | 5824.767% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 3730.243% |
| Cingulate Inc. | 3.08 Million USD | -60559.432% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 63768.301% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -25918.339% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 20225.846% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 2457.372% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 1522.525% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 1871.748% |
| Clearmind Medicine Inc. | -3.94 Million USD | 47528.612% |
| Kronos Bio, Inc. | -36.05 Million USD | 5286.493% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -19773.929% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -128142.464% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 3546.509% |
| Statera Biopharma, Inc. | 14.41 Million USD | -12870.903% |
| ImmunityBio, Inc. | 618.22 Million USD | -202.469% |
| Korro Bio, Inc. | -132.94 Million USD | 1506.571% |
| Kineta, Inc. | -4.54 Million USD | 41278.991% |
| BioVie Inc. | -17.73 Million USD | 10645.347% |
| Codexis, Inc. | -43.27 Million USD | 4421.458% |
| Celularity Inc. | 65.19 Million USD | -2768.443% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 59107.195% |
| Celcuity Inc. | 6.78 Million USD | -27465.94% |
| Virax Biolabs Group Limited | -3.36 Million USD | 55671.148% |
| Cibus, Inc. | -8.07 Million USD | 23248.527% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 44317.025% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -40817.681% |
| IN8bio, Inc. | -16.38 Million USD | 11509.714% |
| Kodiak Sciences Inc. | -103.87 Million USD | 1900.181% |
| Annexon, Inc. | -193.75 Million USD | 1065.104% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -5194172.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 10785.971% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 53329.092% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | -77.368% |
| Eyenovia, Inc. | 1.25 Million USD | -148460.819% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -6850.151% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 57760.746% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 5724.381% |
| Arcellx, Inc. | -296.95 Million USD | 729.698% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 9686.476% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 3276.115% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 9121.749% |
| Moolec Science SA | 117.61 Thousand USD | -1589767.025% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 4969.757% |
| Geron Corporation | 14.76 Million USD | -12568.098% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 5031.531% |
| Royalty Pharma plc | 5.65 Billion USD | 66.952% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 1422.249% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 26853.821% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 34968.304% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 1428.732% |
| Humacyte, Inc. | -22.48 Million USD | 8416.01% |
| Structure Therapeutics Inc. | -124.33 Million USD | 1603.903% |
| 89bio, Inc. | -289.05 Million USD | 746.919% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 7508.042% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 104975.939% |
| Genelux Corporation | -6.89 Million USD | 27204.479% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 6120.6% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -2136.795% |
| Notable Labs, Ltd. | -9.77 Million USD | 19227.844% |
| Liquidia Corporation | -80.17 Million USD | 2432.291% |
| Mustang Bio, Inc. | -3.73 Million USD | 50151.874% |
| Immunovant, Inc. | -635.22 Million USD | 394.373% |
| Quantum-Si incorporated | -118.55 Million USD | 1677.248% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 10746.425% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 45234.878% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -23195.602% |
| Acasti Pharma Inc. | -23 Million USD | 8228.398% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 55633.437% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 11607.755% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 1457.585% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 60103.876% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 8511.02% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 10170.214% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 1204.655% |
| PepGen Inc. | -60.67 Million USD | 3182.146% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 8238.658% |
| United Therapeutics Corporation | -507.7 Million USD | 468.316% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 9876.942% |
| Solid Biosciences Inc. | -47.75 Million USD | 4016.101% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 217007.767% |
| Immuneering Corporation | -54.94 Million USD | 3503.423% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 44585.389% |
| Silo Pharma, Inc. | -3.52 Million USD | 53158.303% |
| Belite Bio, Inc | -87.27 Million USD | 2242.68% |
| XOMA Corporation | -29 Million USD | 6548.062% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 2745.003% |
| Bionomics Limited | 227 Million USD | -723.725% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 1708.106% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 73923.056% |
| uniQure N.V. | -102.95 Million USD | 1916.338% |
| Cassava Sciences, Inc. | -121.13 Million USD | 1643.668% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 44991.857% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -4466.282% |
| Forte Biosciences, Inc. | -11.96 Million USD | 15733.626% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 60533.65% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -1763992.453% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 57760.746% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -20898.742% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 25314.914% |
| Altimmune, Inc. | -134.48 Million USD | 1490.423% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -844.103% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 73923.056% |
| Compugen Ltd. | -12.9 Million USD | 14591.15% |
| Peak Bio, Inc. | 10.34 Million USD | -17984.23% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 660855.477% |
| Benitec Biopharma Inc. | -50.58 Million USD | 3796.845% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 1892.193% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -9418.646% |
| Zura Bio Limited | -99.8 Million USD | 1973.573% |
| PolyPid Ltd. | 6.17 Million USD | -30206.937% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -2422.852% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -9418.646% |
| Instil Bio, Inc. | 75.35 Million USD | -2381.406% |
| argenx SE | -2.02 Billion USD | 192.168% |
| Immunome, Inc. | -97.02 Million USD | 2027.195% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 8412.683% |
| Verona Pharma plc | -220.44 Million USD | 948.264% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 2706.44% |
| Shattuck Labs, Inc. | -121.42 Million USD | 1640.007% |
| CervoMed Inc. | -7.79 Million USD | 24095.572% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 1108.058% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 42860.988% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 1519.416% |
| Moolec Science SA | 117.61 Thousand USD | -1589767.025% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 81828.881% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -11661.815% |
| AnaptysBio, Inc. | -18.15 Million USD | 10402.121% |
| Design Therapeutics, Inc. | -18.15 Million USD | 10402.689% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 2756.879% |
| NeurAxis, Inc. | 145.7 Thousand USD | -1283316.609% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -16548.308% |
| Lumos Pharma, Inc. | -28.49 Million USD | 6662.798% |
| Achilles Therapeutics plc | -126.92 Million USD | 1573.274% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 2706.44% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 285268.896% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 9101.414% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -128142.464% |
| Nutriband Inc. | -251.65 Thousand USD | 743150.263% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 14297.388% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 25233.575% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -449.663% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -7778.399% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 517.89% |
| Palisade Bio, Inc. | -12.06 Million USD | 15601.434% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 1432.709% |
| Beam Therapeutics Inc. | -262.72 Million USD | 811.755% |
| Neurogene Inc. | -131.95 Million USD | 1517.103% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -8471.406% |
| AEON Biopharma, Inc. | -4.88 Million USD | 38418.402% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 595.754% |
| Sesen Bio, Inc. | -112.55 Million USD | 1761.384% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 1972.56% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 79746.63% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 4891.518% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 2345.309% |
| Athira Pharma, Inc. | -88.99 Million USD | 2201.078% |
| Vaccinex, Inc. | -1.28 Million USD | 145281.522% |
| HCW Biologics Inc. | 2.85 Million USD | -65358.526% |
| XOMA Corporation | -29 Million USD | 6548.062% |
| Nektar Therapeutics | 210.24 Million USD | -789.43% |
| Arvinas, Inc. | -313.8 Million USD | 695.901% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -115122.72% |
| Merus N.V. | -192.88 Million USD | 1069.462% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -3017.343% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 27052.119% |
| Rezolute, Inc. | -68.16 Million USD | 2843.132% |
| Clene Inc. | 3.34 Million USD | -55886.168% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 14280.162% |
| BeyondSpring Inc. | -13.75 Million USD | 13694.606% |
| Synlogic, Inc. | -6.68 Million USD | 28072.147% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -164797.531% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 22216.357% |
| Peak Bio, Inc. | 10.34 Million USD | -17984.23% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 2368.792% |
| Krystal Biotech, Inc. | -350.23 Million USD | 633.911% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -1406.496% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 1206.498% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 59328.784% |
| MannKind Corporation | 143.89 Million USD | -1199.479% |
| Ikena Oncology, Inc. | -109.15 Million USD | 1813.088% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 24798.692% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 5749.36% |
| Gossamer Bio, Inc. | 180.35 Million USD | -936.81% |
| CohBar, Inc. | -5.93 Million USD | 31629.638% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 6385.928% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -40853.526% |
| Legend Biotech Corporation | -949.39 Million USD | 296.96% |
| Mural Oncology plc | -255.84 Million USD | 830.893% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -5704.557% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 39796.033% |
| Disc Medicine, Inc. | -358.28 Million USD | 621.919% |
| Champions Oncology, Inc. | 4.81 Million USD | -38759.892% |
| REGENXBIO Inc. | 54.76 Million USD | -3314.289% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 695484.65% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 1338.173% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 20849.409% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 2417.636% |
| Vaxart, Inc. | -8.24 Million USD | 22790.669% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 3826.463% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 1570.474% |
| Cellectis S.A. | -43.85 Million USD | 4363.911% |
| Longeveron Inc. | -2.9 Million USD | 64403.232% |
| Repare Therapeutics Inc. | -107.85 Million USD | 1833.704% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | -93.1% |
| Inozyme Pharma, Inc. | 12 Million USD | -15477.624% |
| Revolution Medicines, Inc. | -608.2 Million USD | 407.452% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 152127.48% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 805.326% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 1346.027% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 12050.777% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 252794.324% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 119.552% |
| Denali Therapeutics Inc. | -74.86 Million USD | 2597.747% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 15693.601% |
| Veru Inc. | 4.77 Million USD | -39020.296% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 16727.583% |
| Cingulate Inc. | 3.08 Million USD | -60559.432% |
| Passage Bio, Inc. | 4.58 Million USD | -40683.817% |
| Context Therapeutics Inc. | -14.44 Million USD | 13040.902% |
| Exicure, Inc. | 5.84 Million USD | -31870.217% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 911.69% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 4825.646% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -11817.265% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 3279.031% |
| Nuvalent, Inc. | -335.38 Million USD | 657.546% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -107718.359% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 2610.59% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 21134.173% |
| OmniAb, Inc. | 9.2 Million USD | -20218.787% |
| Anew Medical, Inc. | 1.43 Million USD | -130439.874% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -11314.76% |
| Lipocine Inc. | -4.75 Million USD | 39429.095% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 1802.606% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -12177.185% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 3791.225% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -7412.205% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 27922.318% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 2940.685% |
| Ocugen, Inc. | -32.52 Million USD | 5849.94% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 2285.145% |
| Q32 Bio Inc. | -37.94 Million USD | 5027.633% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 297860.828% |
| Alumis Inc. Common Stock | -13.52 Million USD | 13921.702% |
| Equillium, Inc. | -22.39 Million USD | 8450.92% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 7413.587% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 5831.3% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 754365.777% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -1295.039% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -58372.108% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -569237.567% |
| Dominari Holdings Inc. | 195 Thousand USD | -958842.564% |
| Edesa Biotech, Inc. | -5.26 Million USD | 35603.512% |
| vTv Therapeutics Inc. | -8.91 Million USD | 21070.483% |
| Bio-Techne Corporation | 267.74 Million USD | -598.397% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 11636.418% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 1683.432% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 22353.219% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 14880.95% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 862.869% |
| Nkarta, Inc. | 57.29 Million USD | -3163.474% |
| BioCardia, Inc. | 212 Thousand USD | -881946.226% |
| Iterum Therapeutics plc | 13.43 Million USD | -13815.3% |